Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05EPV
|
|||
| Former ID |
DNCL001670
|
|||
| Drug Name |
Ozoralizumab
|
|||
| Synonyms |
ATN-103
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
| Company |
Pfizer New York, NY
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01063803) Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.